91鶹ֱ

Manish Kohli
( out of 102 reviews )

Manish Kohli, MD

  • Dr. Manish Kohli graduated in 1990 from the University of Delhi with an Internal Medicine residency training at Cook County Hospital, Chicago from 1993-1996. After completing a 3-year Fellowship in Hematology-Oncology at the University of Arkansas from 1996-99, he joined the Central Arkansas Veteran HealthCare System in Little Rock as Staff physician with a joint appointment at the University of Arkansas for Medical Sciences (UAMS) as Assistant Professor of Medicine. During this time Dr. Kohli authored/co-authored several critical research trials including SWOG-9916, which introduced docetaxel chemotherapy in metastatic castrate resistant stage. In 2005, he joined University of Rochester, New York at the rank of Associate Professor in Medicine in which he oversaw critical areas of genomic and liquid biopsy based research. In June 2008, Dr. Kohli joined Mayo Clinic, Rochester, taking charge to build a comprehensive Genitourinary Oncology translational and clinical research program and was promoted to Consultant/Professor in 2016 in the Department of Oncology. In 2018, he was appointed Vice-Chair of the Department of Genitourinary Oncology and as a Distinguished Moffitt Scholar at the Moffitt Cancer Center, Tampa, also appointed as the Director of the DeBartolo Family Personalized Medicine Institute. He joined Huntsman Cancer Institute-University of Utah in January 2020 as a Presidential Endowed Chair and Professor. Dr. Kohli also holds an Adjunct Faculty rank at the University of Illinois in Urbana Champagne where he works with colleagues on two different RO1s for ultrasensitive liquid biopsy profiling of molecular determinants of a variety of clinical outcomes. His research in advanced prostate cancer focusses on “convergence sciences” which combines population based trials with precision medicine concepts.

    Patient Rating

    4.9 /5
    ( out of 102 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    February 14, 2025
    HUNTSMAN CANCER CENTER

    During a prior appointment he caught my Edema and resulted in cardiac treatment. At this visit he noted my red eyes and suggested treatments for allergies. His concern far exceeds my cancer which he has managed with appreciated success.

    February 02, 2025
    HUNTSMAN CANCER CENTER

    Dr. Kohli is the best doctor we've been to. He really cares about you.

    January 14, 2025
    HUNTSMAN CANCER CENTER

    Dr. Kohli is proficient, competent and personable. He controlled my stage 4 prostate cancer with androgen therapy. Most people I now meet have no idea that I have this (or any) disease.

    November 16, 2024
    HUNTSMAN CANCER CENTER

    Very fortunate to have Dr Kohli as my oncologist.

    October 12, 2024
    HUNTSMAN CANCER CENTER

    He explains things very well and give you the best options.

    October 11, 2024
    HUNTSMAN CANCER CENTER

    Highly competent and personable oncologist who cares about Individuals.

    September 27, 2024
    HUNTSMAN CANCER CENTER

    Dr. Kohli is an experienced oncologist. He is easy to talk with, he listens carefully and he has our confidence.

    September 06, 2024
    HUNTSMAN CANCER CENTER

    Thank you Dr. Kohli for your professional treatment and always preparing for our visit by reviewing all my information before each office visit. Your team is always prepared.

    July 05, 2024
    HUNTSMAN CANCER CENTER

    How would you recommend him to any patient that has cancer?He does a great job

    See More Patient Comments

  • Dr. Manish Kohli graduated in 1990 from the University of Delhi with an Internal Medicine residency training at Cook County Hospital, Chicago from 1993-1996. After completing a 3-year Fellowship in Hematology-Oncology at the University of Arkansas from 1996-99, he joined the Central Arkansas Veteran HealthCare System in Little Rock as Staff physician with a joint appointment at the University of Arkansas for Medical Sciences (UAMS) as Assistant Professor of Medicine. During this time Dr. Kohli authored/co-authored several critical research trials including SWOG-9916, which introduced docetaxel chemotherapy in metastatic castrate resistant stage. In 2005, he joined University of Rochester, New York at the rank of Associate Professor in Medicine in which he oversaw critical areas of genomic and liquid biopsy based research. In June 2008, Dr. Kohli joined Mayo Clinic, Rochester, taking charge to build a comprehensive Genitourinary Oncology translational and clinical research program and was promoted to Consultant/Professor in 2016 in the Department of Oncology. In 2018, he was appointed Vice-Chair of the Department of Genitourinary Oncology and as a Distinguished Moffitt Scholar at the Moffitt Cancer Center, Tampa, also appointed as the Director of the DeBartolo Family Personalized Medicine Institute. He joined Huntsman Cancer Institute-University of Utah in January 2020 as a Presidential Endowed Chair and Professor. Dr. Kohli also holds an Adjunct Faculty rank at the University of Illinois in Urbana Champagne where he works with colleagues on two different RO1s for ultrasensitive liquid biopsy profiling of molecular determinants of a variety of clinical outcomes. His research in advanced prostate cancer focusses on “convergence sciences” which combines population based trials with precision medicine concepts.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Professor
    Academic Divisions Oncology

  • News & Podcasts

    Huntsman Cancer Institute News